2024

Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression
Meissner B, Lang P, Bader P, Hoenig M, Müller I, Meisel R, Greil J, Sauer M, Metzler M, Corbacioglu S, Burkhardt B, Wölfl M, Strahm B, Kafa K, Basu O, Lode H, Gruhn B, Cario H, Ozga A, Zimmermann M, Jarisch A, Beier R
BONE MARROW TRANSPL. 2024 [Epub ahead of print].

2023

CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: Real-World Data from Germany
Bader P, Rossig C, Hutter M, Ayuk F, Baldus C, Bücklein V, Bonig H, Cario G, Einsele H, Holtick U, Koenecke C, Bakhtiar S, Künkele A, Meisel R, Mueller F, Müller I, Penack O, Rettinger E, Sauer M, Schlegel P, Soerensen J, von Stackelberg A, Strahm B, Feuchtinger T, Hauer J, Jarisch A
BLOOD ADV. 2023;7(11):2436-2448.

Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy
Franke A, Wessolowski C, Thaden V, Müller I, Cornils K
GENE THER. 2023;30(7-8):603-611.

Epigenetic Modification of Mesenchymal Stromal Cells Derived from Bone Marrow and Embryonal Tumors to Facilitate Immunotherapeutic Approaches in Pediatric Malignancies
Kruchen A, Johann P, Rekowski L, Müller I
CURR ISSUES MOL BIOL. 2023;45(3):2121-2135.

MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity
Schütze K, Groß M, Cornils K, Wustrau K, Schneppenheim S, Lenhartz H, Korenke G, Janka G, Ledig S, Müller I, Ehl S, Lehmberg K
BLOOD ADV. 2023;7(8):1531-1535.

2022

Hematopoietic Stem Cell Transplantation with Mesenchymal Stromal Cells in Children with Metachromatic Leukodystrophy
Cabanillas Stanchi K, Böhringer J, Strölin M, Groeschel S, Lenglinger K, Treuner C, Kehrer C, Laugwitz L, Bevot A, Kaiser N, Schumm M, Lang P, Handgretinger R, Krägeloh-Mann I, Müller I, Döring M
STEM CELLS DEV. 2022;31(7-8):163-175.

Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial
Eichinger A, Poetschger U, Glogova E, Bader P, Basu O, Beier R, Burkhardt B, Classen C, Claviez A, Corbacioglu S, Deubzer H, Greil J, Gruhn B, Güngör T, Kafa K, Kühl J, Lang P, Lange B, Meisel R, Müller I, Sauer M, Schlegel P, Schulz A, Stachel D, Strahm B, Wawer A, Peters C, Albert M
LEUKEMIA. 2022;36(11):2567-2576.

Maternal versus paternal living kidney transplant donation is associated with lower rejection in young pediatric recipients: A Collaborative Transplant Study report
Engels G, Döhler B, Tönshoff B, Oh J, Kruchen A, Müller I, Süsal C
PEDIATR TRANSPLANT. 2022;26(1):.

The Reconstitution Dynamics of Cultivated Hematopoietic Stem Cells and Progenitors Is Independent of Age
Gotzhein F, Aranyossy T, Thielecke L, Sonntag T, Thaden V, Fehse B, Müller I, Glauche I, Cornils K
INT J MOL SCI. 2022;23(6):.

Immune Ablation and Stem Cell Rescue in Two Pediatric Patients with Progressive Severe Chronic Graft-Versus-Host Disease
Kloehn J, Kruchen A, Schütze K, Wustrau K, Schrum J, Müller I
INT J MOL SCI. 2022;23(23):.

NET Release of Long-Term Surviving Neutrophils
Kolman J, Pagerols Raluy L, Müller I, Nikolaev V, Trochimiuk M, Appl B, Wadehn H, Dücker C, Stoll F, Boettcher M, Reinshagen K, Trah J
FRONT IMMUNOL. 2022;13:815412.

Influence of Fetomaternal Microchimerism on Maternal NK Cell Reactivity against the Child's Leukemic Blasts
Martin L, Kruchen A, Fehse B, Müller I
BIOMEDICINES. 2022;10(3):.

Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients
Schubert M, Berger C, Kunz A, Schmitt A, Badbaran A, Neuber B, Zeschke S, Wang L, Riecken K, Hückelhoven-Krauss A, Müller I, Müller-Tidow C, Dreger P, Kröger N, Ayuk F, Schmitt M, Fehse B
INT J ONCOL. 2022;60(5):.

2021

Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?
Ammer L, Pohl S, Breyer S, Aries C, Denecke J, Perez A, Petzoldt M, Schrum J, Müller I, Muschol N
MOL GENET METAB REP. 2021;26:.

Irradiation-free re-conditioning in children following graft failure of a T cell-depleted graft from a haploidentical parent
Aydin S, Kruchen A, Wustrau K, Doering M, Schrum J, Müller I
BONE MARROW TRANSPL. 2021;56(6):1452-1454.

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome
Bortnick R, Wlodarski M, de Haas V, De Moerloose B, Dworzak M, Hasle H, Masetti R, Starý J, Turkiewicz D, Ussowicz M, Kozyra E, Albert M, Bader P, Bordon V, Cario G, Beier R, Schulte J, Bresters D, Müller I, Pichler H, Sedlacek P, Sauer M, Zecca M, Göhring G, Yoshimi A, Noellke P, Erlacher M, Locatelli F, Niemeyer C, Strahm B
BONE MARROW TRANSPL. 2021;56(11):2732-2741.

Long-term follow-up after the application of mesenchymal stromal cells in children and adolescents with steroid-refractory graft-versus-host disease
Döring M, Cabanillas Stanchi K, Lenglinger K, Treuner C, Gieseke F, Erbacher A, Mezger M, Vaegler M, Schlegel P, Greil J, Bettoni da Cunha Riehm C, Faul C, Schumm M, Lang P, Handgretinger R, Müller I
STEM CELLS DEV. 2021;30(5):234-246.

Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
Hashem H, Bucciol G, Ozen S, Unal S, Bozkaya I, Akarsu N, Taskinen M, Koskenvuo M, Saarela J, Dimitrova D, Hickstein D, Hsu A, Holland S, Krance R, Sasa G, Kumar A, Müller I, Abreu de Sousa M, Delafontaine S, Moens L, Babor F, Barzaghi F, Cicalese M, Bredius R, van Montfrans J, Baretta V, Cesaro S, Stepensky P, Benedicte N, Moshous D, Le Guenno G, Boutboul D, Dalal J, Brooks J, Dokmeci E, Dara J, Lucas C, Hambleton S, Wilson K, Jolles S, Koc Y, Güngör T, Schnider C, Candotti F, Steinmann S, Schulz A, Chambers C, Hershfield M, Ombrello A, Kanakry J, Meyts I
J CLIN IMMUNOL. 2021;41(7):1633-1647.

HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome
Laberko A, Burlakov V, Maier S, Abinun M, Skinner R, Kozlova A, Suri D, Lehmberg K, Müller I, Balashov D, Novichkova G, Holzinger D, Gennery A, Shcherbina A
J ALLERGY CLIN IMMUN. 2021;148(1):250-255.e1.

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
Sahoo S, Pastor V, Goodings C, Voss R, Kozyra E, Szvetnik A, Noellke P, Dworzak M, Starý J, Locatelli F, Masetti R, Schmugge M, De Moerloose B, Catala A, Kállay K, Turkiewicz D, Hasle H, Buechner J, Jahnukainen K, Ussowicz M, Polychronopoulou S, Smith O, Fabri O, Barzilai S, de Haas V, Baumann I, Schwarz-Furlan S, Niewisch M, Sauer M, Burkhardt B, Lang P, Bader P, Beier R, Müller I, Albert M, Meisel R, Schulz A, Cario G, Panda P, Wehrle J, Hirabayashi S, Derecka M, Durruthy-Durruthy R, Göhring G, Yoshimi-Noellke A, Ku M, Lebrecht D, Erlacher M, Flotho C, Strahm B, Niemeyer C, Wlodarski M
NAT MED. 2021;27(10):1806-1817.

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen M, Fischer A, Grimbacher B, Edgar D, Buckland M, Mahlaoui N, Ehl S
J ALLERGY CLIN IMMUN. 2021;148(5):1332-1341.e5.

2020

Accurate In-Vivo Quantification of CD19 CAR-T Cells after Treatment with Axicabtagene Ciloleucel (Axi-Cel) and Tisagenlecleucel (Tisa-Cel) Using Digital PCR
Badbaran A, Berger C, Riecken K, Kruchen A, Geffken M, Müller I, Kröger N, Ayuk F, Fehse B
CANCERS. 2020;12(7):.

Early clinical course after hematopoietic stem cell transplantation in children with juvenile metachromatic leukodystrophy
Beschle J, Döring M, Kehrer C, Raabe C, Bayha U, Strölin M, Böhringer J, Bevot A, Kaiser N, Bender B, Grimm A, Lang P, Müller I, Krägeloh-Mann I, Groeschel S
Molecular and cellular pediatrics. 2020;7(1):12.

Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients
Bleeke M, Johann P, Gröbner S, Alten J, Cario G, Schäfer H, Klapper W, Khoury J, Pfister S, Müller I
PEDIATR BLOOD CANCER. 2020;67(2):e28074.

Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or Chemotherapy
Döring M, Kluba T, Cabanillas Stanchi K, Kahle P, Lenglinger K, Tsiflikas I, Treuner C, Vaegler M, Mezger M, Erbacher A, Schumm M, Lang P, Handgretinger R, Müller I
STEM CELLS DEV. 2020;29(13):811-822.

Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies
Kalwak K, Mielcarek M, Patrick K, Styczynski J, Bader P, Corbacioglu S, Burkhardt B, Sykora K, Drabko K, Gozdzik J, Fagioli F, Greil J, Gruhn B, Beier R, Locatelli F, Müller I, Schlegel P, Sedlacek P, Stachel K, Hemmelmann C, Möller A, Baumgart J, Vora A
BONE MARROW TRANSPL. 2020;55(10):1996-2007.

Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial
Sauer M, Lang P, Albert M, Bader P, Creutzig U, Eyrich M, Greil J, Gruhn B, Holter W, Klingebiel T, Kremens B, von der Leyen H, Mauz-Körholz C, Meisel R, Mischke K, Müller I, Niemeyer C, Peters C, Pohler C, Reinhardt D, Burkhardt B, Schlegel P, Schulz A, Schrum J, Sedlacek P, Strahm B, Woessmann W, Handgretinger R, Zimmermann M, Borkhardt A
LEUKEMIA. 2020;34(2):613-624.

Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia
Strahm B, Loewecke F, Niemeyer C, Albert M, Ansari M, Bader P, Bertrand Y, Burkhardt B, Da Costa L, Ferster A, Fischer A, Güngör T, Gruhn B, Hainmann I, Kapp F, Lang P, Müller I, Schulz A, Szvetnik A, Wlodarski M, Noellke P, Leblanc T, Dalle J
BLOOD ADV. 2020;4(8):1760-1769.

Influence of anti-thymocyte globulin plasma levels on outcome parameters in stem cell transplanted children
Vogelsang V, Kruchen A, Wustrau K, Spohn M, Müller I
INT IMMUNOPHARMACOL. 2020;83:106371.

Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning
Wustrau K, Greil J, Sykora K, Albert M, Burkhardt B, Lang P, Meisel R, Wössmann W, Beier R, Schulz A, Bader P, Chada M, Kühl J, Schlegel P, Speckmann C, Gruhn B, Seidel M, Wawer A, Ozga A, Janka G, Ehl S, Müller I, Lehmberg K
PEDIATR BLOOD CANCER. 2020;67(9):e28523.

2019

Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL
Babor F, Peters C, Manser A, Glogova E, Sauer M, Pötschger U, Ahlmann M, Cario G, Feuchtinger T, Gruhn B, Güngör T, Kremens B, Lang P, Mezger M, Müller I, Mytilineos J, Oevermann L, Pichler H, Scherenschlich N, Schuster F, Siepermann M, Stachel D, Strahm B, Wössmann W, Escherich G, Zimmermann M, Schrappe M, Borkhardt A, Eckert C, Bader P, Uhrberg M, Meisel R
BONE MARROW TRANSPL. 2019;54(11):1847-1858.

Clostridium difficile infection after pediatric solid organ transplantation: a practical single-center experience
Breuer C, Döring S, Rohde H, Rutkowski S, Müller I, Oh J
PEDIATR NEPHROL. 2019;34(7):1269-1275.

Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients
Cabanillas Stanchi K, Queudeville M, Malaval C, Feucht J, Schlegel P, Dobratz M, Seitz C, Müller I, Lang P, Handgretinger R, Döring M
J CANCER RES CLIN. 2019;145(11):2779-2791.

The German National Registry of Primary Immunodeficiencies (2012-2017)
El-Helou S, Biegner A, Bode S, Ehl S, Heeg M, Maccari M, Ritterbusch H, Speckmann C, Rusch S, Scheible R, Warnatz K, Atschekzei F, Beider R, Ernst D, Gerschmann S, Jablonka A, Mielke G, Schmidt R, Schürmann G, Sogkas G, Baumann U, Klemann C, Viemann D, von Bernuth H, Krüger R, Hanitsch L, Scheibenbogen C, Wittke K, Albert M, Eichinger A, Hauck F, Klein C, Rack-Hoch A, Sollinger F, Avila A, Borte M, Borte S, Fasshauer M, Hauenherm A, Kellner N, Müller A, Ülzen A, Bader P, Bakhtiar S, Lee J, Heß U, Schubert R, Wölke S, Zielen S, Ghosh S, Laws H, Neubert J, Oommen P, Hönig M, Schulz A, Steinmann S, Schwarz K, Dückers G, Lamers B, Langemeyer V, Niehues T, Shai S, Graf D, Müglich C, Schmalzing M, Schwaneck E, Tony H, Dirks J, Haase G, Liese J, Morbach H, Foell D, Hellige A, Wittkowski H, Masjosthusmann K, Geberzahn L, Hedrich C, Müller C, Rösen-Wolff A, Roesler J, Zimmermann A, Behrends U, Rieber N, Schauer U, Handgretinger R, Holzer U, Henes J, Kanz L, Boesecke C, Rockstroh J, Schwarze-Zander C, Wasmuth J, Dilloo D, Hülsmann B, Schönberger S, Schreiber S, Zeuner R, Ankermann T, von Bismarck P, Huppertz H, Kaiser-Labusch P, Greil J, Jakoby D, Kulozik A, Metzler M, Naumann-Bartsch N, Sobik B, Graf N, Heine S, Kobbe R, Lehmberg K, Müller I, Herrmann F, Horneff G, Klein A, Peitz J, Schmidt N, Bielack S, Groß-Wieltsch U, Classen C, Klasen J, Deutz P, Kamitz D, Lassay L, Tenbrock K, Wagner N, Bernbeck B, Brummel B, Lara-Villacanas E, Münstermann E, Schneider D, Tietsch N, Westkemper M, Weiß M, Kramm C, Kühnle I, Kullmann S, Girschick H, Specker C, Vinnemeier-Laubenthal E, Haenicke H, Schweigerer L, Müller T, Stiefel M, Belohradsky B, Soetedjo V, Kindle G, Grimbacher B
FRONT IMMUNOL. 2019;10:1272.

Pegvaliase: Immunological profile and recommendations for the clinical management of hypersensitivity reactions in patients with phenylketonuria treated with this enzyme substitution therapy
Hausmann O, Daha M, Longo N, Knol E, Müller I, Northrup H, Brockow K
MOL GENET METAB. 2019;128(1-2):84-91.

EZH2 Inhibition in Ewing Sarcoma Upregulates G Expression for Targeting with Gene-Modified T Cells
Kailayangiri S, Altvater B, Lesch S, Balbach S, Göttlich C, Kühnemundt J, Mikesch J, Schelhaas S, Jamitzky S, Meltzer J, Farwick N, Greune L, Fluegge M, Kerl K, Lode H, Siebert N, Müller I, Walles H, Hartmann W, Rossig C
MOL THER. 2019;27(5):933-946.

Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency -a case report and review of the literature
Schober S, Schilbach K, Doering M, Cabanillas Stanchi K, Holzer U, Kasteleiner P, Schittenhelm J, Schaefer J, Müller I, Lang P, Handgretinger R
BMC PEDIATR. 2019;19(1):346.

Risikofaktoren für einen gemischten Chimerismus nach Stammzelltransplantation mit Treosulfan- oder Melphalanbasierter Konditionierung bei Kindern und Jugendlichen mit primärer Hämophagozytischer Lymphohistiozytose
Wustrau K, Albert M, Bader P, Beier R, Burkhardt B, Chada M, Greil J, Gruhn B, Kühl J, Lang P, Meisel R, Schulz A, Seidel M, Speckmann C, Sykora K, Wawer A, Wößmann W, Ozga A, Janka-Schaub G, Ehl S, Müller I, Lehmberg K
2019. Monatsschrift Kinderheilkunde > Ausgabe 7/2018 . 646-647.

2018

Allogeneic haematopoietic stem cell transplantation eliminates alloreactive inhibitory antibodies after liver transplantation for bile salt export pump deficiency
Brinkert F, Pukite I, Krebs-Schmitt D, Briem-Richter A, Stindt J, Häussinger D, Keitel V, Müller I, Grabhorn E
J HEPATOL. 2018;69(4):961-965.

Bone Marrow-Derived Stem Cells Migrate into Intraepidermal Skin Defects of a Desmoglein-3 Knockout Mouse Model but Preserve their Mesodermal Differentiation
Hünefeld C, Mezger M, Müller-Hermelink E, Schaller M, Müller I, Amagai M, Handgretinger R, Röcken M
J INVEST DERMATOL. 2018;138(5):1157-1165.

CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation
Mainardi C, Ebinger M, Enkel S, Feuchtinger T, Teltschik H, Eyrich M, Schumm M, Rabsteyn A, Schlegel P, Seitz C, Schwarze C, Müller I, Greil J, Bader P, Schlegel P, Martin D, Holzer U, Döring M, Handgretinger R, Lang P
BRIT J HAEMATOL. 2018;180(1):90-99.

Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration
Rapp A, Bindl R, Erbacher A, Kruchen A, Rojewski M, Schrezenmeier H, Müller I, Ignatius A
INT J MOL SCI. 2018;19(9):.

2017

Enzymatic characterization of novel arylsulfatase A variants using human arylsulfatase A-deficient immortalized mesenchymal stromal cells
Böhringer J, Santer R, Schumacher N, Gieseke F, Cornils K, Pechan M, Kustermann-Kuhn B, Handgretinger R, Schöls L, Harzer K, Krägeloh-Mann I, Müller I
HUM MUTAT. 2017;38(11):1511-1520.

Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation
Döring M, Cabanillas Stanchi K, Queudeville M, Feucht J, Blaeschke F, Schlegel P, Feuchtinger T, Lang P, Müller I, Handgretinger R, Heinz W
J CANCER RES CLIN. 2017;143(7):1281-1292.

Hematopoietic stem cell transplantation rescues the hematological, immunological and vascular phenotype in DADA2
Hashem H, Kumar A, Müller I, Babor F, Bredius R, Dalal J, Hsu A, Holland S, Hickstein D, Jolles S, Krance R, Sasa G, Taskinen M, Koskenvuo M, Saarela J, van Montfrans J, Wilson K, Bosch B, Moens L, Hershfield M, Meyts I
BLOOD. 2017;130(24):2682-2688.

Mutations in EXTL3 Cause Neuro-immuno-skeletal Dysplasia Syndrome
Oud M, Tuijnenburg P, Hempel M, van Vlies N, Ren Z, Ferdinandusse S, Jansen M, Santer R, Johannsen J, Bacchelli C, Alders M, Li R, Davies R, Dupuis L, Cale C, Wanders R, Pals S, Ocaka L, James C, Müller I, Lehmberg K, Strom T, Engels H, Williams H, Beales P, Roepman R, Dias P, Brunner H, Cobben J, Hall C, Hartley T, Le Quesne Stabej P, Mendoza-Londono R, Davies E, de Sousa S, Lessel D, Arts H, Kuijpers T
AM J HUM GENET. 2017;100(2):281-296.

Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement
Zoghbi A, Zur Stadt U, Winkler B, Müller I, Escherich G
PEDIATR BLOOD CANCER. 2017;64(11):11.

2016

Feasibility of CD3/CD19 depletion of a bone marrow graft
Bonig H, Müller I
CYTOTHERAPY. 2016;18(10):1345-7.

Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed
Decarolis B, Simon T, Krug B, Leuschner I, Vokuhl C, Kaatsch P, von Schweinitz D, Klingebiel T, Müller I, Schweigerer L, Berthold F, Hero B
BMC CANCER. 2016;16:542.

Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients
Döring M, Cabanillas Stanchi K, Feucht J, Queudeville M, Teltschik H, Lang P, Feuchtinger T, Handgretinger R, Müller I
ANN HEMATOL. 2016;95(2):311-23.

Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients
Groeschel S, Kühl J, Bley A, Kehrer C, Weschke B, Döring M, Böhringer J, Schrum J, Santer R, Kohlschütter A, Krägeloh-Mann I, Müller I
JAMA NEUROL. 2016;73(9):1133-40.

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis
Hartz B, Marsh R, Rao K, Henter J, Jordan M, Filipovich L, Bader P, Beier R, Burkhardt B, Meisel R, Schulz A, Winkler B, Albert M, Greil J, Karasu G, Woessmann W, Corbaciologlu S, Gruhn B, Holter W, Kühl J, Lang P, Seidel M, Veys P, Löfstedt A, Ammann S, Ehl S, Janka G, Müller I, Lehmberg K
BLOOD. 2016;127(25):3281-90.

Treosulfan based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicentre experience
Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins A, Gibson B, Sedlacek P, Krol L, Strahm B, Zaidman I, Kalwak K, Talano J, Woolfrey A, Fraser C, Meyts I, Müller I, Wachowiak J, Bernardo M, Veys P, Sykora K, Gennery A, Slatter M
BLOOD. 2016;128(3):440-8.

Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγcnull Mice
Rapp A, Bindl R, Recknagel S, Erbacher A, Müller I, Schrezenmeier H, Ehrnthaller C, Gebhard F, Ignatius A
PLOS ONE. 2016;11(2):e0147465.

Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation
Schmidt M, Breyer S, Löbel U, Yarar S, Stücker R, Ullrich K, Müller I, Muschol N
ORPHANET J RARE DIS. 2016;11(1):93.

Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients
Teltschik H, Heinzelmann F, Gruhn B, Feuchtinger T, Schlegel P, Schumm M, Kremens B, Müller I, Ebinger M, Schwarze C, Ottinger H, Zips D, Handgretinger R, Lang P
BRIT J HAEMATOL. 2016;175(1):115-22.

2015

Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial
Bader P, Kreyenberg H, von Stackelberg A, Eckert C, Salzmann-Manrique E, Meisel R, Poetschger U, Stachel D, Schrappe M, Alten J, Schrauder A, Schulz A, Lang P, Müller I, Albert M, Willasch A, Klingebiel T, Peters C
J CLIN ONCOL. 2015;33(11):1275 - 84.

Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia
Chao M, Ebell W, Bader P, Beier R, Burkhardt B, Feuchtinger T, Handgretinger R, Hanenberg H, Koehl U, Kratz C, Kremens B, Lang P, Meisel R, Müller I, Roessig C, Sauer M, Schlegel P, Schulz A, Strahm B, Thol F, Sykora K
KLIN PADIATR. 2015;227(3):157-65.

Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation
Döring M, Cabanillas Stanchi K, Mezger M, Erbacher A, Feucht J, Pfeiffer M, Lang P, Handgretinger R, Müller I
BMC CANCER. 2015;15:Art. 607.

Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia
Döring M, Eikemeier M, Cabanillas Stanchi K, Hartmann U, Ebinger M, Schwarze C, Schulz A, Handgretinger R, Müller I
EUR J CLIN MICROBIOL. 2015;34(6):1189-1200.

Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?
Johann P, Müller I
Stem Cells Int. 2015;2015:914632.

Risk of Rotavirus Vaccination for Children with SCID
Klinkenberg D, Blohm M, Hoehne M, Mas Marques A, Malecki M, Schildgen V, Schneppenheim R, Müller I, Schildgen O, Kobbe R
PEDIATR INFECT DIS J. 2015;34(1):114-5.

Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients
Kruchen A, Stahl T, Gieseke F, Binder T, Özcan Z, Meisel R, Kreyenberg H, Bader P, Gruhn B, Greil J, Pfeiffer M, Döring M, Handgretinger R, Fehse B, Müller I
BONE MARROW TRANSPL. 2015;50(10):1367-1370.

Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents
Lehmberg K, Sprekels B, Nichols K, Woessmann W, Müller I, Suttorp M, Bernig T, Beutel K, Bode S, Kentouche K, Kolb R, Längler A, Minkov M, Schilling F, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka G
BRIT J HAEMATOL. 2015;170(4):539-49.

Klinische Praxis - Spenderfindung und Stammzelltransplantation
Müller I
2015. Rettende Geschwister. Schües C, Rehmann-Sutter C (Hrsg.). 2015. Aufl. Münster: Mentis, 25 - 32.

Systemic mesenchymal stem cell administration enhances bone formation in fracture repair but not load-induced bone formation
Rapp A, Bindl R, Heilmann A, Erbacher A, Müller I, Brenner R, Ignatius A
EUR CELLS MATER. 2015;29:22-34.

Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications
Wuchter P, Bieback K, Schrezenmeier H, Bornhäuser M, Müller L, Bönig H, Wagner W, Meisel R, Pavel P, Tonn T, Lang P, Müller I, Renner M, Malcherek G, Saffrich R, Buss E, Horn P, Rojewski M, Schmitt A, Ho A, Sanzenbacher R, Schmitt M
CYTOTHERAPY. 2015;17(2):128-139.

2014

Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation
Döring M, Blume O, Haufe S, Hartmann U, Kimmig A, Schwarze C, Lang P, Handgretinger R, Müller I
EUR J CLIN MICROBIOL. 2014;33(4):629-38.

Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia
Lang P, Teltschik H, Feuchtinger T, Müller I, Pfeiffer M, Schumm M, Ebinger M, Schwarze C, Gruhn B, Schrauder A, Albert M, Greil J, Urban C, Handgretinger R
BRIT J HAEMATOL. 2014;165(5):688-98.

Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis
Lehmberg K, Albert M, Beier R, Beutel K, Gruhn B, Kröger N, Meisel R, Schulz A, Stachel D, Woessmann W, Janka G, Müller I
HAEMATOLOGICA. 2014;99(1):180-4.

Signal-peptide-peptidase-like 2a is required for CD74 intramembrane proteolysis in human B cells
Schneppenheim J, Hüttl S, Kruchen A, Fluhrer R, Müller I, Saftig P, Schneppenheim R, Martin C, Schröder B
BIOCHEM BIOPH RES CO. 2014;451(1):48-53.

2013

Allo-SCT using BU, CY and melphalan for children with AML in second CR
Beier R, Albert M, Bader P, Borkhardt A, Creutzig U, Eyrich M, Ehlert K, Gruhn B, Greil J, Handgretinger R, Holter W, Klingebiel T, Kremens B, Lang P, Mauz-Körholz C, Meisel R, Müller I, Peters C, Reinhardt D, Sedlacek P, Schulz A, Schuster F, Schrauder A, Strahm B, Sykora K, Wössmann W, Zimmermann M, Sauer M
BONE MARROW TRANSPL. 2013;48(5):651-6.

Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience
Beier R, Schulz A, Hönig M, Eyrich M, Schlegel P, Holter W, Stachel K, Ehlert K, Greil J, Nürnberger W, Wössmann W, Bader P, Urban C, Müller I, Suttorp M, Sauer M, Gruhn B, Meisel R, Zimmermann M, Sykora K
BONE MARROW TRANSPL. 2013;48(4):491-501.

Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation
Gieseke F, Kruchen A, Tzaribachev N, Bentzien F, Dominici M, Müller I
EUR J IMMUNOL. 2013;43(10):2741-9.

Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion
Höchst B, Schildberg F, Sauerborn P, Gäbel Y, Gevensleben H, Goltz D, Heukamp L, Türler A, Ballmaier M, Gieseke F, Müller I, Kalff J, Kurts C, Knolle P, Diehl L
J HEPATOL. 2013;59(3):528-35.

One goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disorders
Hünefeld C, Mezger M, Kern J, Nyström A, Bruckner-Tuderman L, Müller I, Handgretinger R, Röcken M
EXP DERMATOL. 2013;22(3):162-7.

Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort
Krägeloh-Mann I, Groeschel S, Kehrer C, Opherk K, Nägele T, Handgretinger R, Müller I
BONE MARROW TRANSPL. 2013;48(3):369-75.

Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.
Marsh R, Rao K, Satwani P, Lehmberg K, Müller I, Li D, Kim M, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis D, Dimmock D, Casper J, Douglas D, Amrolia P, Veys P, Kumar A, Jordan M, Bleesing J, Filipovich A
BLOOD. 2013;121(6):877-883.

Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Oyekunle A, Zander A, Binder M, Ayuketang F, Zabelina T, Christopeit M, Stübig T, Alchalby H, Schafhausen P, Lellek H, Wolschke C, Müller I, Bacher U, Kröger N
ANN HEMATOL. 2013;92(4):487-496.

2012

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, Boelens J, Hewitt A, Schrum J, Schulz A, Müller I, Stein J, Wynn R, Greil J, Sykora K, Matthes-Martin S, Führer M, O'Meara A, Toporski J, Sedlacek P, Schlegel P, Ehlert K, Fasth A, Winiarski J, Arvidson J, Mauz-Körholz C, Ozsahin H, Schrauder A, Bader P, Massaro J, D'Agostino R, Hoyle M, Iacobelli M, Debatin K, Peters C, Dini G
LANCET. 2012;379(9823):1301-1309.

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Döring M, Hartmann U, Erbacher A, Lang P, Handgretinger R, Müller I
BMC INFECT DIS. 2012;12:151.

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation.
Döring M, Müller C, Johann P, Erbacher A, Kimmig A, Schwarze C, Lang P, Handgretinger R, Müller I
BMC INFECT DIS. 2012;12:263.

Eradication of pulmonary aspergillosis in an adolescent patient undergoing three allogeneic stem cell transplantations for acute lymphoblastic leukemia.
Döring M, Zierl A, Mezger M, Lang P, Handgretinger R, Müller I
Case reports in transplantation. 2012;2012:672923.

Siglec-7 tetramers characterize B-cell subpopulations and leukemic blasts.
Gieseke F, Mang P, Viebahn S, Sonntag I, Kruchen A, Erbacher A, Pfeiffer M, Handgretinger R, Müller I
EUR J IMMUNOL. 2012;42(8):2176-2186.

Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedside.
Kuçi S, Henschler R, Müller I, Biagi E, Meisel R
Stem Cells Int. 2012;2012:185943.

IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT.
Pfeiffer M, Schumm M, Müller I, Handgretinger R, Lang P
LEUKEMIA. 2012;26(11):2435-2439.

2011

Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology.
Gómez-Barrena E, Rosset P, Müller I, Giordano R, Bunu C, Layrolle P, Konttinen Y, Luyten F
J CELL MOL MED. 2011;15(6):1266-1286.

Increased cyclosporine concentrations in the absence of cyclosporine administration.
Peter A, Shipkova M, Wieland E, Schleicher E, Müller I
CLIN CHEM. 2011;57(5):670-673.

Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.
Wernicke C, Grunewald T, Juenger H, Kuci S, Kuci Z, Koehl U, Müller I, Doering M, Peters C, Lawitschka A, Kolb H, Bader P, Burdach S, von Luettichau I
Int Arch Med. 2011;4(1):27.

2010

Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells
André M, Erbacher A, Gille C, Schmauke V, Goecke B, Hohberger A, Mang P, Wilhelm A, Müller I, Herr W, Lang P, Handgretinger R, Hartwig U
J IMMUNOL. 2010;185(5):2710-20.

Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
Gieseke F, Böhringer J, Bussolari R, Dominici M, Handgretinger R, Müller I
BLOOD. 2010;116(19):3770-9.

Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis
Holzer U, van Royen-Kerkhof A, van der Torre P, Kuemmerle-Deschner J, Well C, Handgretinger R, Müller I, Wulffraat N
SCAND J RHEUMATOL. 2010;39(1):88-92.

Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells
Holzwarth C, Vaegler M, Gieseke F, Pfister S, Handgretinger R, Kerst G, Müller I
BMC CELL BIOL. 2010;11:11.

Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity
Johann P, Vaegler M, Gieseke F, Mang P, Armeanu-Ebinger S, Kluba T, Handgretinger R, Müller I
BMC CANCER. 2010;10:501.

Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children
Pfeiffer M, Feuchtinger T, Teltschik H, Schumm M, Müller I, Handgretinger R, Lang P
HAEMATOLOGICA. 2010;95(8):1381-8.

Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency
Rohr J, Pannicke U, Döring M, Schmitt-Graeff A, Wiech E, Busch A, Speckmann C, Müller I, Lang P, Handgretinger R, Fisch P, Schwarz K, Ehl S
J CLIN IMMUNOL. 2010;30(2):314-20.

2009

Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1
Battula V, Treml S, Bareiss P, Gieseke F, Roelofs H, de Zwart P, Müller I, Schewe B, Skutella T, Fibbe W, Kanz L, Bühring H
HAEMATOLOGICA. 2009;94(2):173-84.

Dendritic cells: functional aspects of glycosylation and lectins
Erbacher A, Gieseke F, Handgretinger R, Müller I
HUM IMMUNOL. 2009;70(5):308-12.

Diffusion-driven device for a high-resolution dose-response profiling of combination chemotherapy
Ganser A, Roth G, van Galen J, Hilderink J, Wammes J, Müller I, van Leeuwen F, Wiesmüller K, Brock R
ANAL CHEM. 2009;81(13):5233-40.

Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro
Langer H, Stellos K, Steingen C, Froihofer A, Schönberger T, Krämer B, Bigalke B, May A, Seizer P, Müller I, Gieseke F, Siegel-Axel D, Meuth S, Schmidt A, Wendel H, Müller I, Bloch W, Gawaz M
J MOL CELL CARDIOL. 2009;47(2):315-25.

Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany
Schäfer R, Dominici M, Müller I, Horwitz E, Asahara T, Bulte J, Bieback K, Le Blanc K, Bühring H, Capogrossi M, Dazzi F, Gorodetsky R, Henschler R, Handgretinger R, Kajstura J, Kluger P, Lange C, Luettichau I, Mertsching H, Schrezenmeier H, Sievert K, Strunk D, Verfaillie C, Northoff H
CYTOTHERAPY. 2009;11(2):245-55.

2008

Analysis of sternotomy as treatment option for the resection of bilateral pulmonary metastases in pediatric solid tumors
Fuchs J, Seitz G, Ellerkamp V, Dietz K, Bosk A, Müller I, Warmann S, Schäfer J
J SURG ONCOL. 2008;17(4):323-30.

Cellular immune reconstitution after haploidentical transplantation in children
Handgretinger R, Chen X, Pfeiffer M, Schumm M, Müller I, Feuchtinger T, Hale G, Lang P
BIOL BLOOD MARROW TR. 2008;14(1 Suppl 1):59-65.

WT1 protein expression in childhood acute leukemia
Kerst G, Bergold N, Gieseke F, Coustan-Smith E, Lang P, Kalinova M, Handgretinger R, Trka J, Müller I
AM J HEMATOL. 2008;83(5):382-6.

WT1 protein expression in slowly proliferating myeloid leukemic cell lines is scarce throughout the cell cycle with a minimum in G0/G1 phase
Kerst G, Bergold N, Viebahn S, Gieseke F, Kalinova M, Trka J, Handgretinger R, Müller I
LEUKEMIA RES. 2008;32(9):1393-9.

Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells
Kuçi S, Kuçi Z, Schmid S, Seitz G, Müller I, Dufke A, Leimig T, Murti G, Jurecic R, Schumm M, Lang P, Bruchelt G, Bader P, Klingebiel T, Niethammer D, Handgretinger R
CELL PROLIFERAT. 2008;41(1):12-27.

Mesenchymal stem cell therapy for degenerative inflammatory disorders
Müller I, Lymperi S, Dazzi F
CURR OPIN ORGAN TRAN. 2008;13(6):639-44.

Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis
Müller I, Vaegler M, Holzwarth C, Tzaribatchev N, Pfister S, Schütt B, Reize P, Greil J, Handgretinger R, Rudert M
LEUKEMIA. 2008;22(11):2054-61.

Mesenchymal stromal cells: a novel treatment option for steroid-induced avascular osteonecrosis
Tzaribachev N, Vaegler M, Schaefer J, Reize P, Rudert M, Handgretinger R, Müller I
CAN MED ASSOC J. 2008;10(3):232-4.

2007

Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression
Gieseke F, Schütt B, Viebahn S, Koscielniak E, Friedrich W, Handgretinger R, Müller I
BLOOD. 2007;110(6):2197-200.

Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation
Handgretinger R, Chen X, Pfeiffer M, Müller I, Feuchtinger T, Hale G, Lang P
ANN NY ACAD SCI. 2007;1106:279-89.

Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients
Lang P, Müller I, Greil J, Bader P, Schumm M, Pfeiffer M, Hoelle W, Klingebiel T, Heinzelmann F, Belka C, Schlegel P, Kremens B, Woessmann W, Handgretinger R
BLOOD CELL MOL DIS. 2007;40(1):33-9.

Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation
Müller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F, Dominici M, Greil J, Handgretinger R
BLOOD CELL MOL DIS. 2007;40(1):25-32.

Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, Germany
Schäfer R, Dominici M, Müller I, Dazzi F, Bieback K, Godthardt K, Le Blanc K, Meisel R, Pochampally R, Richter R, Skutella T, Steinhoff G, Mitterberger M, Wendel H, Wiskirchen J, Handgretinger R, Northoff H
CYTOTHERAPY. 2007;9(4):397-405.

2006

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E
CYTOTHERAPY. 2006;8(4):315-357.

Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells
Jenner J, Kerst G, Handgretinger R, Müller I
EXP HEMATOL. 2006;34(9):1212-8.

Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects
Lang P, Pfeiffer M, Müller I, Schumm M, Ebinger M, Koscielniak E, Feuchtinger T, Föll J, Martin D, Handgretinger R
KLIN PADIATR. 2006;218(6):321-6.

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM
Müller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A, Viebahn S, Gieseke F, Langer H, Gawaz M, Horwitz E, Conte P, Handgretinger R, Dominici M
CYTOTHERAPY. 2006;8(5):437-44.

In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients
Müller I, Kustermann-Kuhn B, Holzwarth C, Isensee G, Vaegler M, Harzer K, Krägeloh-Mann I, Handgretinger R, Bruchelt G
EXP HEMATOL. 2006;34(10):1413-9.

2005

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement
Horwitz E, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini F, Deans R, Krause D, Keating A
CYTOTHERAPY. 2005;7(5):393-395.

Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR
Kerst G, Kreyenberg H, Roth C, Well C, Dietz K, Coustan-Smith E, Campana D, Koscielniak E, Niemeyer C, Schlegel P, Müller I, Niethammer D, Bader P
BRIT J HAEMATOL. 2005;128(6):774-82.

A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study
Lang P, Schumm M, Greil J, Bader P, Klingebiel T, Müller I, Feuchtinger T, Pfeiffer M, Schlegel P, Niethammer D, Handgretinger R
KLIN PADIATR. 2005;217(6):334-8.

Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction
Schilbach K, Kerst G, Walter S, Eyrich M, Wernet D, Handgretinger R, Xie W, Rammensee H, Müller I, Bühring H, Niethammer D
BLOOD. 2005;106(1):144-9.

2004

Glycosylation and lectins-examples of immunesurveillance and immune evasion
Müller I, Jenner J, Handgretinger R, Riberdy J, Kerst G
HISTOL HISTOPATHOL. 2004;19(2):527-33.

Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation
Otto M, Barfield R, Iyengar R, Gatewood J, Müller I, Holladay M, Houston J, Leung W, Handgretinger R
J IMMUNOTHER. 2004;28(1):73-8.

2003

Receptor activator of nuclear factor kappaB ligand plays a nonredundant role in doxorubicin-induced apoptosis
Müller I, Pfister S, Grohs U, Zweigner J, Handgretinger R, Niethammer D, Bruchelt G
CANCER RES. 2003;63(8):1772-5.

2001

Noncutaneous varicella-zoster virus (VZV) infection with fatal liver failure in a child with acute lymphoblastic leukemia (ALL)
Müller I, Aepinus C, Beck R, Bültmann B, Niethammer D, Klingebiel T
Med Pediatr Oncol. 2001;37(2):145-7.

1998

Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review)
Müller I, Niethammer D, Bruchelt G
INT J MOL MED. 1998;1(2):491-4.

Letzte Aktualisierung aus dem FIS: 19.04.2024 - 00:49 Uhr